Hyperthermic sensitization by hematoporphyrin on glioma cells

References

• Baltuch G. H., Couldwell W. T., Villemure J.-G., Young V. W. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 1993; 33: 495–501
   PubMedGoogle Scholar
• Bonnett R., Lambert C., Land E. J., Scourides P. A., Sinclair R. S., Truscott T. G. The triplet and radical species of hematoporphyrin and some of its derivatives. Photochemistry and Photobiology 1983; 38: 1–8
   PubMed Web of Science ®Google Scholar
• Buettner G. R. Spin trapping: ESR parameters of spin adducts. Free Radical Biology Medicine 1987; 3: 259–303
   PubMed Web of Science ®Google Scholar
• Buettner G. R., Need M. J. Hydrogen peroxide and hydroxyl free radical production by hematoporphyrin derivative, ascorbate and light. Cancer Letters 1985; 25: 297–304
   PubMed Web of Science ®Google Scholar
• Buettner G. R., Oberley L. W. Apparent production of superoxide and hydroxyl radicals by hematoporphyrin and light as seen by spin-trapping. Federation of European Biochemical Societies Letters 1980; 121: 161–164
   PubMed Web of Science ®Google Scholar
• Cheeseman K. H., Slater T. F. An introduction to free radical biochemistry. British Medical Bulletin 1993; 49: 481–493
   PubMed Web of Science ®Google Scholar
• Christensen T., Wahl A., Smedshammer L. Effects of haematoporphyrin derivative and light in combination with hyperthermia on cells in culture. British Journal of Cancer 1984; 50: 85–89
   PubMed Web of Science ®Google Scholar
• DaSilva V. F., Raaphorst G. P., Goyal R., Feeley M. Drug cytotoxicity at elevated temperature. In vitro study on the U-87 MG glioma cell line. Journal of Neurosurgery 1987; 67: 885–888
   PubMedGoogle Scholar
• Dewhirst M. W. Future directions in hyperthermia biology. International Journal of Hyperthermia 1994; 10: 339–345
   PubMed Web of Science ®Google Scholar
• Evensen J. F., Sommer S., Moan J., Christensen T. Tumor-localizing and photosensitizing properties of the main component of hematoporphyrin derivative. Cancer Research 1984; 44: 482–486
   PubMed Web of Science ®Google Scholar
• Gi H., Yamashita J., Handa H. Synergism and hyperthermia and hematoporphyrin derivative. Japanese Journal of Cancer Chemotherapy 1984; 11: 835–839
   PubMedGoogle Scholar
• Hariharan P. V., Courtney J., Eleczko S. Production of hydroxyl radicals in cells systems exposed to hematoporphyrin and red light. International Journal of Radiation Biology 1980; 37: 691–694
   Web of Science ®Google Scholar
• Henderson B. W., Miller A. C. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiation Research 1986; 108: 196–205
   PubMedGoogle Scholar
• Hill J. S., Kaye A. H., Sawyer W. H., Morstyn G., Megison P. D., Stylli S. S. Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 1990; 26: 248–254
   PubMedGoogle Scholar
• Issels R. D., Fink R. M., Lengfelder E. Effects of hyperthermic conditions on the reactivity of oxygen radicals. Free Radical Research Communications 1986; 2: 7–18
   PubMedGoogle Scholar
• Johnston R. B., Jr., Keele B. B., Jr., Misra H. P., Lehmeyer J. E., Webb L. S., Baehner R. L., Rajagopalan K. V. The role of superoxide anion generation in phagocytic bactericidal activity. Journal of Clinical Investigation 1975; 55: 1357–1372
   PubMed Web of Science ®Google Scholar
• Kahn A. U. Direct spectral evidence of the generation of singlet molecular oxygen (1δg) in the reaction of potassium superoxide with water. Journal of the American Chemical Society 1981; 103: 6516–6517
   Google Scholar
• Kakinuma K., Tanaka R., Takahashi H., Watanabe M., Nakagawa T., Kuroki M. Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia. Journal of Neurosurgery 1996; 84: 180–184
   PubMed Web of Science ®Google Scholar
• Kaye A. H., Morstyn G., Ashcroft R. G. Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. Neurosurgery 1985; 17: 883–890
   PubMed Web of Science ®Google Scholar
• Kaye A. H., Morstyn G., Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase 1–2 study. Journal of Neurosurgery 1987; 67: 500–505
   PubMed Web of Science ®Google Scholar
• Kellogg E. W., III, Fridovich I. Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by xanthine oxidase system. Journal of Biological Chemistry 1975; 250: 8812–8817
   PubMed Web of Science ®Google Scholar
• Kostron H., Swartz M. R., Miller D. C., Martuza R. L. The interaction of hematoporphyrin derivative, light, and ionizing radiation in rat glioma model. Cancer 1986; 57: 964–970
   PubMed Web of Science ®Google Scholar
• Krishna M. C., Dewhirst M. W., Freidman H. S., Cook J. A., Degraff W., Samuni A., Mitchell J. B. Hyperthermic sensitization by the radical initiator 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH). I. In vitro studies. International Journal of Hyperthermia 1994; 10: 271–281
   PubMed Web of Science ®Google Scholar
• Laws E. R., Jr., Cortese D. A., Kinsey J. H., Eagan R. T., Anderson R. E. Photoradiation therapy in the treatment of malignant brain tumors: A phase I (feasibility) study. Neurosurgery 1981; 9: 672–678
   PubMed Web of Science ®Google Scholar
• Levendag P. C., Marijnissen H. P. A., De Ru V. J., Versteeg J. A. C., Van Rhoon G. C., Star W. M. Interaction of interstitial photodynamic therapy and interstitial hyperthermia in a rat-rhabdomyosarcoma—a pilot study. International Journal of Radiation Oncology, Biology, Physics 1988; 14: 139–145
   PubMed Web of Science ®Google Scholar
• Moan J., Pettersen E. O., Christensen T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of hematoporphyrin. British Journal of Cancer 1979; 39: 398–407
   PubMed Web of Science ®Google Scholar
• Oberley L. M., Buettner G. R. Role of superoxide dismutase in cancer: A review. Cancer Research 1979; 39: 1141–1149
   PubMed Web of Science ®Google Scholar
• Omar R. A., Yano S., Kikkawsa Y. Antioxidant enzymes and survival of normal and Simian virus 40-transformed mouse embryo cells after hyperthermia. Cancer Research 1987; 47: 3473–3476
   PubMed Web of Science ®Google Scholar
• Peterson D. A., McKelvey S., Edmondson P. R. A hypothesis for the molecular mechanism of tumor killing by porphyrins and light. Medical Hypotheses 1981; 7: 201–205
   PubMedGoogle Scholar
• Salcman M. Survival in glioblastoma: Historical perspective. Neurosurgery 1980; 7: 435–439
   PubMed Web of Science ®Google Scholar
• Salcman M. Epidemiology and factors affecting survival. Malignant Cerebral Glioma, M. L. J. Apuzzo. American Association of Neurological Surgeons, Park Ridge, IL 1990; 95–109
   Google Scholar
• Takahashi H., Tanaka R., Watanabe M., Kakinuma K., Suda T., Takahashi S., Masuda H., Saito A., Nakajima T. Clinical results of RF interstitial hyperthermia for malignant brain tumors. Japanese Journal of Hyperthermic Oncology 1995; 11: 61–67
   Google Scholar
• Takakura K., Abe H., Tanaka R., Kitamura K., Miwa T., Takeuchi K., Yamamoto S., Kageyama N., Handa H., Mogami H., Nishimoto A., Uozumi T., Matsutani M., Nomura K. Effects of ACNU and radiotherapy on malignant gliomas. Journal of Neurosurgery 1986; 64: 53–57
   PubMed Web of Science ®Google Scholar
• Tanaka R., Kim C. H., Yamada N., Saito Y. Radiofrequency hyperthermia for malignant brain tumors: preliminary results of clinical trials. Neurosurgery 1987; 21: 478–483
   PubMed Web of Science ®Google Scholar
• Umemura S., Yumita N., Nishigaki R., Umemura K. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Japanese Journal of Cancer Research 1990; 81: 962–966
   PubMedGoogle Scholar
• Urano M., Kahn J. The change in hypoxic and chronically hypoxic cell fraction in murine tumors treated with hyperthermia. Radiation Research 1983; 96: 549–559
   PubMed Web of Science ®Google Scholar
• Wallner K. E., De Gregorio M. W., Li G. C. Hyperthermic potentiation of cis-diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Research 1986; 46: 6242–6245
   PubMed Web of Science ®Google Scholar
• Watanabe M., Tanaka R., Hondo H., Kuroki M. Effects of antineoplastic agents and hypthermia on cytotoxicity toward chronically hypoxic glioma cells. International Journal of Hyperthermia 1992; 8: 131–138
   PubMed Web of Science ®Google Scholar
• Weishaupt K. R., Gomer C. J., Dogherty T. J. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Research 1976; 36: 2326–2329
   PubMed Web of Science ®Google Scholar
• Wharen R. E., Jr, Anderson R. E., Laws E. R., Jr. Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues. Neurosurgery 1983; 12: 446–450
   PubMed Web of Science ®Google Scholar
• Wharen R. E., Jr., So S., Anderson R. E., Laws E. R., Jr. Hematoporphyrin derivative photocytotoxicity of human glioblastoma in cells culture. Neurosurgery 1986; 19: 495–501
   PubMedGoogle Scholar
• Woodburn K. W., Stylli S., Hill J. S., Kaye A. H., Reiss J. A., Phillips D. R. Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy. British Journal of Cancer 1992; 65: 321–328
   PubMed Web of Science ®Google Scholar